H oxidase (Nox)2 and Nox4 are the isoforms of Nox expressed in the macula densa (MD). MD-derived superoxide (O 2 Ϫ ), primarily generated by Nox2, is enhanced by acute ANG II stimulation. However, the effects of chronic elevations in ANG II during ANG II-induced hypertension on MD-derived O 2 Ϫ are unknown. We infused a slow pressor dose of ANG II (600 ng·min Ϫ1 ·kg Ϫ1 ) for 2 wk in C57BL/6 mice and found that mean arterial pressure was elevated by 22.3 Ϯ 3.4 mmHg (P Ͻ 0.01). We measured O 2 Ϫ generation in isolated and perfused MDs and found that O 2 Ϫ generation by the MD was increased from 9.4 Ϯ 0.9 U/min in control mice to 34.7 Ϯ 1.8 U/min in ANG II-induced hypertensive mice (P Ͻ 0.01). We stimulated MMDD1 cells, a MD-like cell line, with ANG II and found that O 2 Ϫ generation increased from 921 Ϯ 91 to 3,687 Ϯ 183 U·min Ϫ1 ·10 5 cells Ϫ1 , which was inhibited with apocynin, oxypurinol, or NS-398 by 46%, 14%, and 12%, respectively. We isolated MD cells using laser capture microdissection and measured mRNA levels of Nox. Nox2 and Nox4 levels increased by 3.7 Ϯ 0.17-and 2.6 Ϯ 0.15-fold in ANG II-infused mice compared with control mice. In MMDD1 cells treated with Nox2 or Nox4 small interfering (si)RNAs, ANG II-stimulated O 2 Ϫ generation was blunted by 50% and 41%, respectively. In cells treated with p22 phox siRNA, ANG II-stimulated O 2 Ϫ generation was completely blocked. In conclusion, we found that a subpressor dose of ANG II enhances O 2 Ϫ generation in the MD and that the sources of this O 2 Ϫ are primarily Nox2 and Nox4.
KIDNEYS ARE VITAL in maintaining adequate extracellular fluid volume, and they do so by regulating the excretion of Na ϩ and water. Abnormalities in Na ϩ and water excretion may result in inappropriate salt and water retention, which can facilitate hypertension. One of the mechanisms that the kidney possesses to regulate salt excretion is via the macula densa (MD). MD cells are modified epithelial cells located at the distal segment of the thick ascending limb (TAL) that comprise an integral component of the juxtaglomerular apparatus (JGA). MD cells serve as luminal sensors of NaCl concentration; they sense increase in NaCl delivery, to which they respond by initiating a sequence of events that results in an increase in adenosine and/or ATP release. These, in turn, constrict the afferent arterioles, lower capillary hydraulic pressure, decrease the single nephron glomerular filtration rate (SNGFR), and decrease tubular flow back to normal levels. This series of events is collectively termed as the tubuloglomerular feedback (TGF) response. The TGF response establishes a negative feedback by which a change in tubular flow to the MD induces a reciprocal change in SNGFR, thus preventing acute fluctuations of flow and NaCl delivery in the distal nephron (7, 42, 51, 53, 59, 60) . Hence, TGF limits urinary volume and Na ϩ excretion and thus may contribute to the maintainance of salt and water homeostasis. Any abnormality in the TGF response may alter the salt and water balance. Indeed, several studies (4, 6, 28, 30, 39, 45, 58, 59) have reported that TGF responses are enhanced in several experimental models of hypertension and that this may contribute to the hypertension.
MD cells not only initiate the TGF response, but the same signals also regulate renin release (54) , which also plays a key role in the regulation of renal hemodynamics, salt and water excretion, and blood pressure. Due to the importance of these two mechanisms, they are tightly regulated by various factors, including ANG II, nitric oxide (NO), and superoxide (O 2 Ϫ ) (56) . Consequently, interactions between these factors may have an important effect on renal function. For example, NO in the MD blunts the TGF response via a cGMP-dependent pathway. O 2 Ϫ enhances TGF responsiveness mediated by scavenging NO and reducing NO bioavailability in the MD (35, 36, 50, 64) . Thus, any factor that alters the levels of O 2 Ϫ may potentially modulate TGF, resulting in abnormal salt and water homeostasis. Therefore, it is important to understand the sources and mechanisms that alter O 2 Ϫ production in the MD. The main source of O 2 Ϫ in the kidney is NAD(P)H oxidase (Nox), which has been shown to be present in the renal cortex, medulla, and blood vessels (21, 61) . Nox has been implicated in several models of hypertension. Our recent study (64) demonstrated that Nox2 and Nox4 are the primary isoforms of Nox expressed in the MD. Moreover, we found that MDderived O 2 Ϫ is enhanced by acute ANG II stimulation and by increases in NaCl and that this increase in O 2 Ϫ is primarily generated by the Nox2 isoform (20, 64) . However, the effects of chronic elevations in ANG II on MD-derived O 2 Ϫ are unknown. Because inappropriate chronic elevations in ANG II may cause enhanced TGF and thus salt-sensitive hypertension, in this study, we determined the changes in expression and function of Nox in the MD after chronic ANG II stimulation.
Telemetry transmitter implantation.
Briefly, C57BL/6 mice (18 -20 g, Harlan) were anesthetized with inhaled isoflurane (Butler Chemicals). A small incision was made in the middle of the neck for the insertion of the telemetry transmitter (PA-C10, Data Sciences). The catheter of the transmitter was placed in the left carotid artery and advanced down to the aortic arch. The body of the transmitter was placed subcutaneously in the right ventral flank of the animal. Mice were allowed to recover for 10 days.
Minipump insertion. Osmotic minipumps (Alzet) were primed and filled with either ANG II (600 ng·kg Ϫ1 ·min Ϫ1 ) or saline (control). On the day of surgery, the animals, which had 10 days to recover from the telemetry transmitter implantation, were again anesthetized with isoflurane. Under sterile conditions, a small incision was made in the midscapular area on the animal's back. Using a hemostat, the subcutaneous tissue was separated and spread so as to create a small pouch in which the minipump was inserted. After insertion, the wound was sutured, and animals were allowed to recover for a day. Measurements of mean arterial pressure (MAP) were started on the second day after minipump implantation at 10-min intervals.
Laser capture microdissection and real-time PCR. Laser capture microdissection (LCM) and real-time PCR were used to isolate MD cells and to measure Nox2 and Nox4 mRNA levels with methods we have previously described (19, 37, 64) . Briefly, kidneys from C57BL/6 mice were removed and snap frozen in Optimal Cutting Temperature medium. Frozen sections (8 m thick) were obtained and then stained and dehydrated using an Arcturus Histogene frozen section staining kit (Life Technologies, Carlsbad, CA). MD cells were dissected with an Arcturus LCM System (Model Veritas). Real-time PCR was used to quantify mRNA levels of Nox2 and Nox4. Total RNA from MMDD1 cells was extracted with the RNeasy Micro kit (Qiagen) following the manufacturer's instructions. One microgram of total RNA was reverse transcribed at 25°C for 5 min, 42°C for 45 min, and 85°C for 5 min using the iScript cDNA Synthesis kit (Bio-Rad) following the manufacturer's instructions. Real-time PCR was performed in a C1000TM Thermal Cycler real-time PCR machine (Bio-Rad). ␤-Actin was used as a housekeeping gene.
Isolation and microperfusion of the JGA and measurement of O 2 Ϫ with dihydroethidium. We used methods similar to those we have previously described to isolate and microperfuse the MD with the attached glomerulus (19, 36) . Briefly, the kidneys were removed and sliced along the corticomedullary axis. Single superficial intact glomeruli were microdissected together with adherent tubular segments consisting of portions of the TAL, MD, and early distal tubule. Using a micropipette, samples were transferred to a temperature-regulated chamber mounted on an inverted microscope (TE2000-S, Nikon). The glomeruli were positioned so the MD could be visualized using a holding pipette. TALs were cannulated with an array of glass pipettes. MDs were perfused with physiological saline solution containing (in mmol/l) 10 HEPES, 1.0 CaCO3, 0.5 K2HPO4, 4.0 KHCO3, 1.2 MgSO4, 5.5 glucose, 0.5 Na acetate, and 0.5 Na lactate (pH 7.4); NaCl was 10 or 80 mmol/l. The luminal perfusion rate was 40 nl/min and was controlled with a pump (11 plus, Harvard Apparatus, Holliston, MS). The bath consisted of modified essential medium containing 0.15% BSA and was exchanged continuously at a rate of 1 ml/min. We used the O 2 Ϫ -sensitive fluorescent dye dihydroethidium to detect O 2 Ϫ levels, as we have previously described (33, 34) . Briefly, once the TAL was perfused, MD cells were loaded with 10 M dihydroethidium in 0.1% DMSO plus 0.1% pluronic acid from the lumen for 30 min and then washed for 20 min. Loaded MD cells were exposed to 380-and 490-nm light to excite dihydroethidium and oxyethidium, respectively. Emitted fluorescence from dihydroethidium was recorded using a 420-nm dichroic mirror with a 460/ 50-nm band-pass filter; for oxyethidium, we used a 565-nm dichroic mirror with a 605/55-nm band-pass filter. Square-shaped regions of interest were set inside the cytoplasm of MD cells, and their mean intensity was recorded every 5 s for 2 min. We recorded and calculated the rate of the changes for oxyethidium/dihydroxyethidium as an indicator of O 2 Ϫ production. Since we have previously found that increased luminal NaCl induced NO release by the MD (32, 34), we added the NO synthase inhibitor N-nitro-L-arginine methyl ester (10 Ϫ4 mol/l) to the bath and lumen while measuring O 2 Ϫ to eliminate its reaction with NO, as we have previously reported (33, 34) .
Measurement of O 2
Ϫ with lucigenin-enhanced chemiluminescence in MMDD1 cells. Our experiments used MMDD1 cells, a MD-like cell line (kindly provided by Dr. J. Schnermann, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD) (62), in a manner similar to our previously described studies (20, 64, 65) . MMDD1 cells were stimulated by ANG II (10 Ϫ6 -10 Ϫ10 mol/l) for 12 h. O 2 Ϫ production in MMDD1 cells was determined using a lucigeninenhanced chemiluminescence assay, as previously described (20, 64) . Briefly, MMDD1 cells (10-cm dish) were washed with PBS twice, trypsinized in the dish, and kept in 9 or 12 ml Krebs-HEPES buffer [which contained (in mmol/l) 115 NaCl, 20 HEPES, 1.17 K 2HPO4, 1.17 MgSO 4, 4.3 KCl, 1.3 CaCl2, 25 NaHCO3, 11.7 glucose, and 0.1 NAD(P)H, with pH adjusted to 7.4]. Lucigenin (5 ϫ 10 Ϫ6 mol/l) was then added to the samples, which were incubated for 30 min at 37°C with oxygen bubbling. A 0.5-ml sample was transferred into 1.6-ml polypropylene 8 ϫ 50-mm tubes, and, using a Sirius luminometer (Berthold Detection Systems, Pforzheim, Germany), O 2 Ϫ was then measured following the manufacturer's instructions. Luminescence was measured for 10 s with a delay of 5 s.
Preparations for small interfering RNA. Nox2, Nox4, and p22 phox small interfering (si)RNAs were designed and synthesized by Santa Cruz Biotechnology (Santa Cruz, CA). siRNA transfection was performed following the manufacturer's instructions as previously described (64, 65) . Briefly, the transfection of the siRNA was performed using TransMessenger Transfection Reagent from QIANGEN (Germantown, MD) according to the manufacturer's instructions. Scrambled siRNAs were synthesized and used as negative controls. Twentyfour hours before transfection, MMDD1 cells were transferred onto six-well plates and transfected with 2 g of each siRNA duplex using TransMessenger Transfection Reagent for 3 h in medium devoid of serum and antibiotics. MMDD1 cells were then washed once with PBS and grown in complete medium. Gene silencing was monitored by measuring RNA after incubation for 24 h. Statistical analysis. Data were collected as repeated measures over time under different conditions. We tested only the effects of interest using ANOVA for repeated measures and a post hoc Fisher's leastsignificant-difference test or a Student's paired t-test when appropriate. Changes were considered to be significant if P Ͻ 0.05. Data are presented as means Ϯ SE.
RESULTS

Subpressor ANG II infusion induced hypertension in mice.
To demonstrate the effect of a slow pressor dose of ANG II on blood pressure, we infused ANG II with a minipump at a dose of 600 ng·min Ϫ1 ·kg Ϫ1 for 2 wk and measured MAP with telemetry in C57BL/6 mice. We found that basal MAP was 101 Ϯ 3.1 mmHg and that this started to gradually elevate from day 5 of minipump insertion in the ANG II-treated group. Blood pressure continued to rise and reached a peak of 123 Ϯ 3.8 mmHg on days 10 -14 of the infusion (n ϭ 7, P Ͻ 0.01). MAP of control mice infused with saline did not vary significantly (n ϭ 5; Fig. 1) .
O 2 Ϫ generation by the MD is enhanced in ANG II-induced hypertensive mice. To determine whether O 2
Ϫ generation by MD cells increases after ANG II infusion, we isolated and perfused the JGA and measured O 2 Ϫ generation using dihydroethidium in mice infused with ANG II or saline for 2 wk by minipumps. The MD was perfused with 80 mM NaCl solution in the presence of N-nitro-L-arginine methyl ester (10 Ϫ4 mol/l) in the bath and lumen. O 2 Ϫ generation by the MD was 9.4 Ϯ 0.9 U/min in control mice. It increased to 34.7 Ϯ 1.8 U/min in ANG II-induced hypertensive mice (n ϭ 6, P Ͻ 0.01; Fig. 2) .
To determine the source of O 2 Ϫ generation, we used the Nox inhibitor apocynin and repeated the above protocol. In the presence of apocynin, O 2 Ϫ generation by the MD was 2.1 Ϯ 0.3 U/min in control mice and increased to 12.4 Ϯ 2.3 U/min in ANG II-induced hypertensive mice (n ϭ 5, P Ͻ 0.01; Fig. 2 , respectively (Fig. 4) . These data again point to the fact that ANG IIstimulated O 2 Ϫ generation in MMDD1 cells arises primarily from Nox. (Fig. 6B ). These data indicate that ANG II enhances O 2 Ϫ generation from both Nox2 and Nox4 isoforms of Nox in MMDD1 cells.
DISCUSSION
ANG II, the key effector peptide of the renin-angiotensin system, is vital in the initiation and progression of hypertension, vascular hypertrophy, and atherosclerosis (29) . These actions of ANG II, including vascular smooth muscle constriction, elevated systemic blood pressure, endothelial dysfunction, vascular remodeling, and retention of Na ϩ , are mediated through ROS generated by Nox (23, 63) . ROS are generated after ANG II-induced activation of ANG II type 1 (AT 1 (20, 64) . This raised the possibility that in situations associated with increased ANG II and oxidative stress, like hypertension, the increased TGF sensitivity and abnormal Na ϩ handling may be mediated by Rac-enhanced increases in O 2 Ϫ . However, these studies also used acute ANG II, which does not mimic pathophysiological conditions where ANG II is chronically elevated. In this study, we accomplished this by chronically infusing subpressor doses of ANG II. This chronic ANG II induces oxidative stress and salt-sensitive hypertension, increases proinflammatory factors, and leads to progressive renal injury (11-14, 16, 18, 24, 25, 31, 43, 44, 48, 49) . Indeed, this chronic ANG II model is recognized as a good prototype of human hypertension and has been found to induce a gradual and sustained elevation in blood pressure over a period of time (8, 17, 22, 52) . The dose needed to cause these subpressor ANG II-induced changes varies based on the route and species of animals. In mice, it fluctuates anywhere from 400 to 1,000 ng·kg Ϫ1 ·min Ϫ1 (2, 5, 9, 10, 15, 52, 57). In our study, we used ANG II at a dose of 600 ng·min Ϫ1 ·kg Ϫ1 since we found that this dose consistently elevated MAP by about 20 mmHg (Fig.  1 ). While this dose elevated blood pressure, it is not as well known whether subpressor ANG II alters oxidative stress at the MD level and, if so, what the primary sources are for ANG II-induced O 2 Ϫ at the MD. Hence, the aim of this study was to determine the changes in the expression as well as function of Nox2 and Nox4 in the MD after chronic ANG II stimulation. The key findings from our present study are that both Nox2 and Nox4 mRNA levels are increased in the MD after ANG II stimulation and also that the chronic ANG II stimulus enhanced O 2 Ϫ generation from both Nox2 and Nox4. O 2 Ϫ generated in the MD scavenges NO and plays a vital role in enhancing the TGF response.
Enhanced TGF responses have been found in several models of systemic hypertension. In this study, experiments were performed on the isolated perfused JGA and in a MD-like cell line, MMDD1 cells, to demonstrate that chronic subpressor ANG II elevated O 2 Ϫ in both scenarios. In isolated perfused JGAs from chronic ANG II-treated mice, we noted that chronic low-dose ANG II elevated O 2 Ϫ levels compared with control mice. This indicates that subpressor ANG II induced O 2 Ϫ in the MD, thereby contributing to the enhanced TGF and ANG II-induced hypertension. To determine the possible source of this O 2 Ϫ , apocynin was used in the JGA preparation. We found that apocynin blunted O 2 Ϫ production in ANG II-treated animals. We confirmed these observations with in vitro experiments using cultured MMDD1 cells. In these cells, ANG II-induced O 2 Ϫ logarithmically increased with increasing ANG II concentrations from 10 Ϫ10 to 10 Ϫ7 log mol/l (Fig. 3A) . O 2 Ϫ production progressively increased from the time of initiation of the ANG II stimulation and reached a peak at 12 h after ANG II stimulation (Fig. 3B ). This again reaffirms our findings that subpressor ANG II induces O 2 Ϫ in the MD of mice. Moreover, O 2 Ϫ from these cells was blunted the most after the addition of apocynin. This suggests that chronic subpressor ANG II increases O 2 Ϫ through the Nox system. Also, since apocynin only effectively inhibits Nox2, but not Nox4, it can be hypothesized that in the MD, in a chronic ANG II milieu, O 2 Ϫ may be generated not only from Nox2 but also Nox4. We are aware of a recent publication (27) in which the authors concluded that apocynin may act as a scavenger of ROS rather than a specific inhibitor of Nox in some cells. However, this conclusion was primarily based on an experiment in which apocynin at a concentration of 1,000 M reduced the amount of O 2 Ϫ in cell-free systems. In addition, 1,000 M apocynin did not have any effect on O 2 Ϫ levels in human embryonic kidney-293 cells transfected with Nox2 and p47. These data clearly show that apocynin is not simply an O 2 Ϫ scavenger. In our preparation, we used apocynin at a concentration of 10 M. Given that this concentration is 100 times less than that needed to scavenge O 2 Ϫ , it is unlikely that apocynin acts via this mechanism in our preparation. We also realize that the concentration of oxypurinol we used in this study was pretty high, which could act as an antioxidant (3) . Since xanthine oxidase is not a primary source of O 2 Ϫ in the MD, the results will not affect our conclusions for this study.
Our previous studies have demonstrated that the two isoforms of Nox in the MD are Nox2 and Nox4. To confirm this, we used LCM techniques to isolate the MD, as previously described (64) . Real-time PCR was used to measure Nox2 and Nox4 mRNA levels. We noted that ANG II-treated mice had an about fourfold increase in Nox2 and a threefold increase in Nox4 compared with control mice. This suggests that both Nox2 and Nox4 isoforms of Nox are increased in chronic ANG II-induced hypertensive mice. Next, to isolate which isoform(s) of Nox is involved in mediating the chronic ANG II-induced O 2 Ϫ increases, in separate experiments, we used silencing RNAs against Nox2 and Nox4 to silence these genes. We found that silencing these genes blunted the effects of chronic ANG II on O 2 Ϫ generation; this suggests that unlike acute ANG II stimulation, chronic ANG II stimulates both Nox2 and Nox4 in the MD to generate O 2 Ϫ . To further test our hypothesis, we used p22 phox siRNA to inhibit the function of both Nox2 and Nox4. We found that subpressor ANG II-induced O 2 Ϫ generation in MMDD1 cells treated with siRNA against p22 phox was completely blocked, signifying that both Nox2 and Nox4 are activated by ANG II. Compared with Nox2, there is a paucity of studies defining the significance and mechanism of action of the Nox4 isoform. A study (38) on Nox4 has suggested that it is the primary source of O 2 Ϫ in TALs after acute ANG II stimulation. Welch et al. (41) infused rats with chronic ANG II, measured SNGFR in rats treated with siRNA against p22 phox , and found that SNGFR in these animals was significantly lowered, implying that Nox plays a very significant role in the regulation of TGF-mediated SNGFR. Moreover, unlike Nox2, Nox4 is also a significant source of H 2 O 2 , which is essential in the regulation of vascular activity (1, 47, 55) . In the present study, we mainly focused only on the generation of O 2
Limitations of the present study are that we were unable to perform all the protocols in vivo and in isolated perfused JGAs. We had to use a cell line, namely, MMDD1 cells. We expect that MMDD1 cells will yield results that are complementary with the results obtained in perfused JGAs and in vivo. We realize that, phenotypically, the MMDD1 cell line may not be exactly the same as actual MD cells in vivo (26) . Any endpoint differences between MMDD1 and actual MD cells should be interpreted with caution.
Although salt sensitivity is considered to be primarily an isolated defect in pressure natriuresis, along with this deficiency there exists an important physiological mechanism that plays a part in the renal physiological and structural changes leading to salt sensitivity. This mechanism is known as resetting the set point of TGF. In humans, resetting TGF contributes to the development of salt-sensitive hypertension (4, 30, 46) . In these hypertensive models, administration of angiotensin-converting enzyme inhibitors or AT 1 receptor blockers significantly reduce the sensitivity of the TGF mechanism (6, 28, 39, 45) , and peritubular infusions of ANG II enhanced the TGF responsiveness (40) . Thus, ANG II may contribute to the development of hypertension in part through its positive modulating effects on the TGF mechanism.
In summary, we found that a chronic subpressor dose of ANG II enhances O 2 Ϫ generation in the MD. The source of this O 2 Ϫ is primarily from Nox. Moreover, our data also indicate that chronic ANG II stimulates both Nox2 and Nox4.
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